Clinical Trials
20 trialsNCT07586813 2026-05-14
N01-A-PICIT-GI
Peking University People's Hospital
Phase 2 Recruiting
NCT03050268 2026-04-23
SJFAMILY
St. Jude Children's Research Hospital
Recruiting
NCT06861088 2026-02-02
CATIQ P3
Quercis Pharma AG
Phase 3 Recruiting
NCT06018896 2024-06-06
PTCA199-4
Fudan University
Phase 2 Recruiting
NCT01931644 2024-04-18
At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions
Sanguine Biosciences
Completed
NCT03878524 2024-03-04
Serial Measurements of Molecular and Architectural Responses to Therapy (SMMART) PRIME Trial
OHSU Knight Cancer Institute
Phase 1 Terminated
NCT05964621 2023-11-28
PaTR-VTE
University of Thessaly
Unknown
NCT05154474 2022-05-03
SPACE2
Weprom
Unknown
NCT00438906 2021-06-18
CAPS 3
Johns Hopkins University
Completed
NCT02628860 2020-04-28
FCM
National Cancer Center, Korea
Phase 2 Completed
NCT03471468 2020-02-17
DOMICA
Poitiers University Hospital
Phase NA Terminated
NCT01286987 2019-01-10
Study of Talazoparib, a PARP Inhibitor, in Patients With Advanced or Recurrent Solid Tumors
Pfizer
Phase 1 Completed
NCT01444456 2017-03-20
Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia
Amgen
Completed
NCT00966277 2016-12-12
Dalteparin for Primary Venous Thromboembolism (VTE) Prophylaxis in Pancreatic Cancer Patients
M.D. Anderson Cancer Center
Phase 4 Completed
NCT01325558 2016-07-15
A Study of ALT-836 in Combination With Gemcitabine for Locally Advanced or Metastatic Solid Tumors
Altor BioScience
Phase 1 Completed
NCT00580021 2016-01-28
Clinical Outcomes in Hereditary Cancer
Memorial Sloan Kettering Cancer Center
Withdrawn
NCT01135849 2015-11-17
B-Receptor Signaling in Cardiomyopathy
Stanford University
Completed
NCT00294203 2014-04-15
Pilot Study of Epoetin Alfa for Patients Having Abdominal or Pelvic Surgery for Cancer
University of Florida
Phase 1 Completed
NCT00660205 2012-03-26
GIVTE
University of Aarhus
Completed
NCT00060502 2011-05-17
A Study of the Safety and Effectiveness of Infliximab (Remicade) in Patients With Pancreatic Cancer Related Cachexia
Centocor, Inc.
Phase 2 Completed